Diabetes Mellitus in Pancreatic Cancer Patients in the Czech Republic: Sex Differences

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F12%3A00062710" target="_blank" >RIV/00216224:14110/12:00062710 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/65269705:_____/12:#0001702

Výsledek na webu

<a href="http://dx.doi.org/10.1155/2012/414893" target="_blank" >http://dx.doi.org/10.1155/2012/414893</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1155/2012/414893" target="_blank" >10.1155/2012/414893</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Diabetes Mellitus in Pancreatic Cancer Patients in the Czech Republic: Sex Differences

Popis výsledku v původním jazyce

Aims. The prevalence of diabetes mellitus in pancreatic cancer patients and control subjects was compared. Methods. Retrospective evaluation of 182 pancreatic cancer patients and 135 controls. The presence of diabetes was evaluated and the time period between the diagnosis of diabetes and pancreatic cancer was assessed. A subanalysis based on patient sex was conducted. Results. Diabetes mellitus was present in 64 patients (35.2%) in pancreatic cancer group and in 27 patients (20.0%) in control group (chi(2) = 8.709; P = 0.003). In 18 patients (28.1% of diabetic pancreatic cancer patients) diabetes was new-onset. Diabetes was new-onset in 23.3% of females compared to 38.1% of males (chi(2) = 1.537; P = 0.215). The overall prevalence of diabetes was significantly higher among female pancreatic cancer patients (25% versus 43.9%; chi(2) = 7.070, P = 0.008), while diabetes prevalence was equally represented in the control group patients (22.1% versus 17.2%;.2 = 0.484, P = 0.487). Conclusion

Název v anglickém jazyce

Diabetes Mellitus in Pancreatic Cancer Patients in the Czech Republic: Sex Differences

Popis výsledku anglicky

Aims. The prevalence of diabetes mellitus in pancreatic cancer patients and control subjects was compared. Methods. Retrospective evaluation of 182 pancreatic cancer patients and 135 controls. The presence of diabetes was evaluated and the time period between the diagnosis of diabetes and pancreatic cancer was assessed. A subanalysis based on patient sex was conducted. Results. Diabetes mellitus was present in 64 patients (35.2%) in pancreatic cancer group and in 27 patients (20.0%) in control group (chi(2) = 8.709; P = 0.003). In 18 patients (28.1% of diabetic pancreatic cancer patients) diabetes was new-onset. Diabetes was new-onset in 23.3% of females compared to 38.1% of males (chi(2) = 1.537; P = 0.215). The overall prevalence of diabetes was significantly higher among female pancreatic cancer patients (25% versus 43.9%; chi(2) = 7.070, P = 0.008), while diabetes prevalence was equally represented in the control group patients (22.1% versus 17.2%;.2 = 0.484, P = 0.487). Conclusion

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FP - Ostatní lékařské obory

OECD FORD obor

—

Projekt

<a href="/cs/project/NS9861" target="_blank" >NS9861: Výskyt asymptomatického karcinomu pankreatu u pacientů atypickým (labilním) diabetes mellitus</a><br>

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

EXPERIMENTAL DIABETES RESEARCH

ISSN

1687-5214

e-ISSN

—

Svazek periodika

Neuveden

Číslo periodika v rámci svazku

červen

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

5

Strana od-do

—

Kód UT WoS článku

000307570100001

EID výsledku v databázi Scopus

—